These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 17430777

  • 21. The socioeconomic consequences of multiple sclerosis: a controlled national study.
    Jennum P, Wanscher B, Frederiksen J, Kjellberg J.
    Eur Neuropsychopharmacol; 2012 Jan; 22(1):36-43. PubMed ID: 21669514
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. A prospective study of the financial costs of multiple sclerosis at different stages of the disease.
    Orlewska E, Mierzejewski P, Zaborski J, Kruszewska J, Wicha W, Fryze W, Drozdowski W, Skibicka I, Mirowska-Guzel D, Czlonkowski A, Czlonkowska A.
    Eur J Neurol; 2005 Jan; 12(1):31-9. PubMed ID: 15613144
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Socioeconomic burden of psoriatic arthritis in Hong Kong: direct and indirect costs and the influence of disease pattern.
    Zhu TY, Tam LS, Leung YY, Kwok LW, Wong KC, Yu T, Kun EW, Li EK.
    J Rheumatol; 2010 Jun; 37(6):1214-20. PubMed ID: 20360186
    [Abstract] [Full Text] [Related]

  • 27. The effects of economic disadvantage on psychological well-being and quality of life among people with multiple sclerosis.
    McCabew MP, De Judicibus M.
    J Health Psychol; 2005 Jan; 10(1):163-73. PubMed ID: 15576507
    [Abstract] [Full Text] [Related]

  • 28. Social economic costs and health-related quality of life in patients with amyotrophic lateral sclerosis in Spain.
    López-Bastida J, Perestelo-Pérez L, Montón-Alvarez F, Serrano-Aguilar P, Alfonso-Sanchez JL.
    Amyotroph Lateral Scler; 2009 Aug; 10(4):237-43. PubMed ID: 18821088
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Annual direct and indirect health care costs of chronic idiopathic urticaria: a cost analysis of 50 nonimmunosuppressed patients.
    Delong LK, Culler SD, Saini SS, Beck LA, Chen SC.
    Arch Dermatol; 2008 Jan; 144(1):35-9. PubMed ID: 18209166
    [Abstract] [Full Text] [Related]

  • 33. Estimation of the cost of MS in Europe: extrapolations from a multinational cost study.
    Sobocki P, Pugliatti M, Lauer K, Kobelt G.
    Mult Scler; 2007 Sep; 13(8):1054-64. PubMed ID: 17623729
    [Abstract] [Full Text] [Related]

  • 34. Quantifying the role of natalizumab in health and economic outcomes in multiple sclerosis.
    Brandes DW, Shaya FT, Pill MW.
    Am J Manag Care; 2010 Jun; 16(6 Suppl):S171-7. PubMed ID: 20615053
    [Abstract] [Full Text] [Related]

  • 35. The economic burden of stroke in Italy. The EcLIPSE Study: Economic Longitudinal Incidence-based Project for Stroke Evaluation.
    Gerzeli S, Tarricone R, Zolo P, Colangelo I, Busca MR, Gandolfo C.
    Neurol Sci; 2005 Jun; 26(2):72-80. PubMed ID: 15995823
    [Abstract] [Full Text] [Related]

  • 36. Economic cost of dementia patients according to the limitation of the activities of daily living in Korea.
    Kang IO, Lee SY, Kim SY, Park CY.
    Int J Geriatr Psychiatry; 2007 Jul; 22(7):675-81. PubMed ID: 17171741
    [Abstract] [Full Text] [Related]

  • 37. Treatment experience, burden and unmet needs (TRIBUNE) in MS study: results from five European countries.
    Karampampa K, Gustavsson A, Miltenburger C, Eckert B.
    Mult Scler; 2012 Jun; 18(2 Suppl):7-15. PubMed ID: 22623122
    [Abstract] [Full Text] [Related]

  • 38. Economic costs associated with an MS relapse.
    O'Connell K, Kelly SB, Fogarty E, Duggan M, Buckley L, Hutchinson M, McGuigan C, Tubridy N.
    Mult Scler Relat Disord; 2014 Nov; 3(6):678-83. PubMed ID: 25891546
    [Abstract] [Full Text] [Related]

  • 39. Costs and quality of life in multiple sclerosis patients with spasticity.
    Svensson J, Borg S, Nilsson P.
    Acta Neurol Scand; 2014 Jan; 129(1):13-20. PubMed ID: 23683163
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.